EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
180 hedge funds and large institutions have $756M invested in Eagle Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 182 → 180 (-2)
25% less call options, than puts
Call options by funds: $7.99M | Put options by funds: $10.6M
Holders
180
Holding in Top 10
3
Calls
$7.99M
Puts
$10.6M
Top Buyers
| 1 | +$14.2M | |
| 2 | +$8.59M | |
| 3 | +$7.51M | |
| 4 |
Man Group
London,
United Kingdom
|
+$6.73M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.48M |
Top Sellers
| 1 | -$21.5M | |
| 2 | -$14.7M | |
| 3 | -$10.1M | |
| 4 |
HEC
Hudson Executive Capital
New York
|
-$8.87M |
| 5 |
Two Sigma Investments
New York
|
-$4.9M |